Latest Breaking News On - David nakasone - Page 3 : comparemela.com

Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024

IRVINE, Calif., Feb. 20, 2024 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,.

United statesDavid nakasoneAdrienne kempCorporate communicationsTarsus pharmaceuticals incTarsus pharmaceuticalsMeibomian gland disease

Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference

Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesDavid nakasoneAdrienne kempBobak azamianCorporate communicationsTarsus pharmaceuticals incChief executive officerSixth annual guggenheim healthcare talksNew york cityTarsus pharmaceuticalsMeibomian gland disease

Tarsus Pharmaceuticals, Inc (NASDAQ:TARS) Q3 2023 Earnings Call Transcript

Operator: Good afternoon and welcome to the Tarsus Pharmaceuticals Third Quarter 2023 Financial Results Conference Call. As a reminder, this call is being recorded.

United statesDavid nakasoneWilliam blairBobak azamianJason gerberryJeff farrowBobby azamianAziz mottiwalaTim lugoAmerican academy of ophthalmologyBiggest geothermal companiesTarsus pharmaceuticals third quarterTarsus pharmaceuticals incTarsus pharmaceuticalsCall transcript novemberResults conference

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesAdrienne kempDavid nakasoneTarsus pharmaceuticals incCorporate communicationsTarsus pharmaceuticalsMeibomian gland disease

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

IRVINE, Calif., Nov. 01, 2023 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients,.

United statesAdrienne kempDavid nakasoneTarsus pharmaceuticals incCorporate communicationsTarsus pharmaceuticalsMeibomian gland disease